View original document

The full text on this page is automatically extracted from the file linked above and may contain errors and inconsistencies.

FEDERAL RESERVE BANK OF PHILADELPHIA

MARCH

Drugs and Bugs
How Did Banks Make Out in 1958?




1 5
9 9

DRUGS

On Philadelphia’s Spring Garden Street west

logicals in Marietta (Lancaster County), and

of Broad there once stood a huge, hoary brick

the shiny quarters in Radnor house the labora­

building where Baldwin made locomotives—

tories and administrative functions of the com­

great, big steam locomotives. On the same spot

pany reaching as far west as Idaho.
National Drug, which merged with Vick Chem­

now stands a tidy, modern structure where Smith,
Kline & French makes pills— teeny, tiny pills.

ical, has a stand in Philadelphia; McNeil Labora­

Just around the corner on Broad Street, a mere

tories recently absorbed by Johnson & Johnson

seven-iron shot north of Spring Garden in a

(surgical dressings) has been making drugs in

building of the nineties vintage, Philadelphia’s

Philadelphia for fourscore years, and in nearby

famed Sharp & Dohme has been making pills for

Hammonton, New Jersey, Whitehall Laboratories

generations. Merged with Merck in 1953, Merck,

makes pharmaceuticals in a brand-new plant. It

Sharp & Dohme now also operates a 300-acre

is not intended to create the impression that

laboratory and pill plantation in the suburbs at

Philadelphia has a half-nelson on the pharma­

West Point.

ceutical industry, but the Quaker City is the focus

Wyeth Laboratories — a division of Ameri­

of an important drug-manufacturing area largely

can Home Products— makes pharmaceuticals in

because of the city’s longstanding prominence as

Philadelphia, antibiotics in West Chester, bio-

a center of materia medica.

2




b usin ess r e v ie w

makes a lot out of a little.

MATERIA ECONOMICA

How the industry stacks up for size depends
upon what it is compared with in the American

Pharmaceuticals are as old as Egypt and as new

family of almost 500 manufacturing industries.

as nucleonics. The industry is research-rooted

Alongside the big ones, it is little; alongside the

and market-minded. Producers are lavish in ex­

little ones, it is big. Why not dispense with the

penditures on product development and equally

confusion of numbers and just call pharmaceu­

lavish in cultivating their markets. It’s an indus­

ticals a big little industry?

try of small fixed-capital investment but heavy
selling expenses. Some companies are large;

Who's who?

others small. Some make a full line of drugs;

Drug

others specialize in a limited line. The industry

classes— the ethical and the proprietary (no un­

is split between firms selling products for usage

ethical implications). The ethical houses make

manufacturing

concerns

fall into two

under professional direction and those selling

products which are used under professional di­

products advertised to consumers.
The industry is highly competitive, handsomely

rections and the purchase of these drugs may
require both money and a doctor’s prescription.

profitable, alert, healthy, vigorous, unseasonal,

Money alone buys the products of the proprietary

uncyclical, public-spirited, and wise in public
relations. It is subject to Government scrutiny

concerns. Ethical drugs are things like antibiotics,
sulfonamides, vaccines— high-voltage stuff for the

for malpractices, and to investor scrutiny for

killer diseases. Proprietary drugs are low-voltage

profitable practices. Companies usually compete

concoctions like aspirin products, cold remedies,

with each other like cats and dogs but during

and laxatives.

emergencies like wars or epidemics, they cooper­

Proprietary drugs are often but erroneously

ate like brothers. Moreover, companies compete

called “ patent” medicines. To get a patent in

with themselves. New and more effective drugs
are forever pushing older products off the pro­

this country, you must come up with something

duction lines and off druggists’ shelves. By cease­

usually the ethical houses that develop new drugs

less striving to put itself out of business, the

and get them patented. Thus, patent medicines

industry puts itself more firmly into business.

are seldom patented medicine.

new and original. In the realm of medicine, it is

Among the most widely known ethical manu­

A big little industry

facturers are Abbott Laboratories; American

By latest count, the pharmaceutical industry con­

Home Products; Lederle; Lilly; Merck, Sharp &

sists of 1,163 concerns that employ 77,000 people

Dohme; Parke, Davis; Pfizer; Schering; Searle;

who work up $482 million of raw materials into

Smith, Kline & French; and Upjohn. Some of the

$1,643 million of pills, capsules, ampules, liquids,

leading firms in the proprietary field are Bristol-

salves, ointments, hormones, vaccines, antibiotics,

Myers;

and other finished products. Few if any other

Plough; Sterling; Vick; and Warner-Lambert.

industries have as great a spread, percentage­

Ethicals have been growing fast and now account

Mead Johnson;

Norwich Pharmacal;

wise, between raw-material costs and value of

for almost three-quarters of the total pharmaceu­

products shipped. In other words, the industry

tical sales.




3

b usin ess re v ie w

The trouble with the twofold division, just ex­

You get the feeling you are going through a

plained, is that it is getting fuzzy. Heretofore

laboratory— and as a matter of fact you are. A

strictly ethicals are going into proprietaries, and

shop of this kind is essentially a laboratory, with

some of the proprietary firms are going into

a production department attached to make the

ethicals. Invading each other’ s preserves is done

laboratory self-supporting. It is significant that

either by developing new-product lines or by way

the word “ laboratories” appears in the title of a

of consolidation and merger.

number of leading manufacturers of ethical
drugs. With or without the word— and note the

A tour through a pill mill

plural-—no respectable pharmaceutical house is

In some respects, a pill mill, or tablet factory

without them. In many lines of business it is

for technical accuracy, is like any other fac­

fashionable to have laboratories, but in this busi­

tory. In other respects, it isn’t. As you might

ness, laboratories are indispensable.

suppose, a pill— like any other product— must

It isn’t exactly unusual to find a library at­

be designed, the ingredients are carefully weighed

tached to a business organization, but in a phar­

according to the recipe, and shaping takes place

maceutical house you find a library where the

on little tablet-punching machines that punch
them out at the rate of 2,000 a minute. What a

librarian seldom languishes in loneliness. Maga­
zines by the hundreds and books by the thou­

sickly people we must be! After spray coating,

sands, mostly highly technical stuff and in all

comes polishing done on a machine that resem­

languages— and believe it or not, people read­

bles a concrete mixer. The hissing and the swish­

ing them.

ing in the pill-polishing department are perhaps
the most distinctive sounds the tourist through a

The mouse and monkey department

pill factory takes with him. Bottling and packag­

In their native habitat, mice are mice, and mon­

ing are high-speed, mechanized operations— the

keys are monkeys— but in a pill mill, both are

same as in a dairy or a distillery. There is endless

guinea pigs. So are chicks, cats, dogs, rabbits,

checking and inspecting and testing, which is

and an occasional horse, cow, or bull. Mice and

quite understandable, for here is a business where

monkeys seem to be the favorite guinea pigs,

an error cannot be tolerated because it might

judged by the number kept on hand to try out
new drugs. Breeding pharmaceutical mice is a

be fatal.
The machinery, materials, and inhabitants of
a pill factory are also what you might expect—

special business engaged in by several firms along
the Atlantic Seaboard.

huge tanks with interconnecting piping, auto­

The monkey business is different. Monkeys

claves, centrifuges, filter presses, kettledrums full

come from Burma, India, Malaya, Pakistan,

of mentholated mixtures, herbs, carboys, drums,

Thailand, and the Philippines. They are flown

scales and pails, and all kinds of professional

into this country on regularly scheduled cargo

paraphernalia like beakers and bottles, Bunsen

planes and by charter flights. Immigrant monkeys

burners, pipettes and petri dishes aplenty, and

are now arriving in this country at an annual rate

professional people wearing long white coats, and

of about 225,000 animals. The average cost of a

some also wearing masks to scare away the deadly

monkey is about $50, and they are used not only

bugs they are playing with.

by the major drug companies but also by re­

4




b usin ess r e v ie w

search foundations, biological laboratories, medi­

apiece to the patient. Five to $10 worth usually

cal schools, Federal agencies such as the National

gets you on your feet, when laid low by a bug of

Institute of Health, the armed services, the

some sort. Precisely what bug bit you is a fact

Atomic Energy Commission, etc.

you or your doctor may never know. But this
you know and lived to tell— that the antibiotic

MICROCOSMIC COMPETITION
For all our scientific fuss

made you well. And what are antibiotics?

Research is still a blunderbuss,

Scientific witchcraft

We fire a monstrous charge of shot

A sufficiently powerful microscope trained on a

And sometimes hit, but mostly not!

drop of water or a speck of soil would reveal

— “ T he S kills

E conomist ,” by

more living things and a greater variety than the

Kenneth E. Boulding (Howard, Allen, Inc.,
publishers, Cleveland 6, Ohio)

population of New York City! You would see

of the

an unbelievably colorful jungle of wiggling wild
George Washington was often exposed to

life— strange beings waging unremitting warfare

enemy fire, but what finally killed him was not a

with each other for food, water, space, and exist­

bullet but a bug. During his final illness the doc­

ence. These microbic organisms, including molds

tors urged him to dring a sickening mixture of

and bacteria, are on the borderline between

molasses, vinegar, and butter, but he couldn’t

plants and animals and look like an arboreal

take it. Then he was made to eat a menthol vapor

nightmare. So tiny that a teaspoonful would num­

rub. The doctors drained a pint of blood and
wrapped around his throat a flannel cloth soaked

ber millions of millions, they multiply and fight
furiously, and as they grow they become visible

in menthol vapor rub. They bathed his feet in
warm water, applied a blister of Spanish flies to

like the mold on a piece of stale bread.

his throat, bled him another pint, made him

bugs to the layman, are not all vicious, as might

gargle with sage tea and vinegar, and bled

be imagined. Some microbes are useful, like

him again.

those employed to make wine, beer, bread, and

Microbes, molds, fungi, bacteria, or just plain

As the General got worse, he was given a

cheese, through a process called fermentation.

heavier bleeding— a full quart— and was given a

These, the helpful microbes— technically known

laxative of calomel and an emetic of tartar. A

as saprophytes— might be called the “ goodies.”

young physician who advised slitting the Gen­

Then there are the harmful microbes— the para­

eral’s windpipe below the point of mucous ob­

sites — that bring pneumonia, typhoid, small­

struction, to assist breathing (today’s tracheot­
omy operation), was overruled; instead, blisters

pox, tuberculosis, etc., that might be called the
“ badies.” It is only within the past few years

of wheat bran were applied to the General’s feet.

that we have learned how to use the goodies to

Then the General died.

fight the badies.

In the light of today’s knowledge, Washing­

Among

chemical

substances

produced

by

ton’s terminal illness would probably be diag­

microbes are two groups of compounds: (1) the

nosed as streptococcic laryngitis. Too bad the

growth type, which are stimulating— vitamins—

doctors didn’t have any antibiotics.

they are the good-will microbes; (2) the growth-

Antibiotics come in tiny capsules at 50 cents




inhibiting or antibiotics are the ill-will microbes.

5

b usin ess re v ie w

Thus, antibiotics are chemical substances pro­

of the microcosmic competition in the labora­

duced by a microorganism, or identical substances

tories throughout the industry— competition in

produced by chemical synthesis which have the

the little world of the microbes. Each company

capacity to inhibit the growth of other micro­

tried to outdo the other in bringing out the most

organisms or to destroy them.

effective bug killer.

Penicillin, the first useful antibiotic, was dis­
covered in England by Alexander Fleming in

Laboratory technicians worked overtime to
discover new antibiotics. As fast as they found

1928, who found its ability to eliminate disease—causing bacteria in vitro, that is, under test-tube

them, they tried them out on mice and monkeys,
and then on man. After getting approval of the

conditions. In 1939-1941, two other Englishmen
— Drs. Howard W. Florey and Ernst D. Chain—

Food and Drug Administration as to the purity,
safety, and potency of the new antibiotic, and a

found a way to use penicillin as an effective de­

patent to ward off competitors, the new drug

stroyer of bacteria in vivo, that is, in laboratory

went to market. Competition was fast and furious.

animals and in persons. For their discoveries, the

New antibiotics appeared in rapid successsion.

three microbe hunters received the Nobel Prize

American Cyanimid’s Lederle Laboratories pa­

in Medicine and Physiology in 1945.

tented Chlorotetracycline in 1949, and the same

Prodigious efforts were made during World
War II to improve the potency and productivity

year Parke, Davis patented Chloramphenicol.
Patents were granted in 1950 on Pfizer’s Oxyte-

of penicillin. In 1943, the Department of Agri­

tracycline, and in 1951 on Lilly’s Penicillin V,

culture’s Peoria laboratory found a penicillin

in 1953 on Wyeth’s (American Home Products)

mold which increased the yield to about 100

Benzathine penicillin, and Lilly’s Erythromycin,

times that of the original Fleming mold. Further

and Pfizer’s Tetracycline. All of these and two

increases in yield were obtained at the Carnegie
Institution, where the Peoria mold was bom­

dozen others that might be mentioned are the
broad spectrum antibiotics— drugs effective in

barded with X rays, and still greater increases

fighting a wider range of germs than the original

in yield were obtained by University of Wis­

narrow spectrum, penicillin.

consin

geneticists,

who

used

ultraviolet-ray

bombardment.

For all we know, most of the antibiotics just
mentioned may now be obsolete because the

The first significant product of company-

competition maintains such a fast pace that one

financed research was streptomycin, discovered

company’s product is rapidly superseded by an

in 1943 by Dr. Selman A. Waksman and his
assistants working at Rutgers University on a

improved antibiotic from either its own labora­
tory or that of a competitor. Unlike formerly,

grant by Merck & Company which magnani­

when it took about ten years to develop a new

mously gave up its contractual “ sole right to

drug, which was good for about 15 years, it now

develop commercially” any results of this re­

takes much less time to bring out a new product,

search. Streptomycin was the first drug to attack

and its life span is likely to be short.

the tuberculosis germ directly in the body of
the victim.

MACROCOSMIC COMPETITION

The basic microbial discoveries outside the

Competition in the laboratories in the little world

pharmaceutical industry touched off a stampede

of microbes is only half the competition in this

6




b usin ess r e v ie w

industry. The other half takes place in the wide,

The hailstorm of "happy pills"

wide world of markets. This is macrocosmic
competition.

Canst thou not minister to a mind diseas’d,
Pluck from the memory a rooted sorrow,

How to get a drug on the market

Raze out the written troubles of the brain,

How a drug gets on the market depends on

And with some sweet oblivious antidote

whether it is a proprietary or an ethical drug.

Cleanse the stuff’d bosom of that perilous stuff

If it is a proprietary, you know very well how

Which weighs upon the heart?

it gets on the market— the same way any other

— “ M a c b e t h A c t V, Scene 3.

product gets there: advertising in the newspapers,
magazines, on radio and TV. The gunman who

More hospital beds are occupied by mental

specializes in robbing lone women proprietors of

patients than the total of all other types of dis­

small retail stores is all set to get his fourth

ability combined. In the past half-dozen years,

victim.

about to

numerous medical agents have been found which

close in on him, comes the commercial— about

calm the patient and make him more amenable

somebody’s stomach sweetener, illustrated with

to other types of therapy. The market is flooded

animated cartoons so dearly beloved by little

with more than 30 different types of tranquilizers,

children. Oftimes the advertising department has

professionally known as ataractic drugs (from

just discovered a new ingredient that causes the

the Greek word, ataraxia, meaning freedom from

remedy to rotate clockwise in ever-widening cir­

mental disturbance), and popularly known as
“ I-don’t-care pills,” “ mood pills,” “ happy pills,”

Just when the police

are

cles throughout the entire abdominal cavity as
prima facie proof of its curative power. And
only 590 at your nearest drugstore.

etc. In calling all doctors, the discoverers of new
pharmaceuticals set up quite a clamor.

Most ethical drugs, though bought by the ulti­

One way of calling to the attention of doctors

mate consumer, require a doctor’s prescription,

a new drug is the obvious one of advertising in

as already mentioned. Consequently, the adver­

the medical journals, of which there are a great

tising must be pitched at the doctors, and that

many— journals and advertisements.

calls for a technique quite unlike proprietary

Probably more effective is direct mail. Doctors

pitching. When an ethical house has developed a

are the recipients of a constant and enormous

new drug and is ready to launch it, the manufac­
turer virtually ignores the market of 175 million

barrage of direct mail advertising designed to

potential consumers and directs his efforts on the
country’s 225,000 physicians. It sounds easy but

mind them of drugs no longer new. Big drug
companies think nothing of spending $500,000

in reality it is tough because most doctors are

in the first year’s promotional mailing on a new

very busy people who put in an average work

product. A widespread practice is to send along

week of better than 60 hours. So the problem is

with the literature samples of the new drugs, and

inform them about new drugs as well as to re­

how to catch them in an idle moment to tell them

sometimes also mechanical pens or pencils with

all about a brand-new drug they have never

which to write the prescriptions, and other gad­

heard about. This may be explained with refer­

gets like prescription blanks, rulers, calendars,

ence to the advent of tranquilizers.

desk pads, etc.




7

b usin ess re v ie w

Then there are sales promotion devices such

nervous little mice and tamed ferocious rhesus

as motion pictures, closed-circuit television pro­

monkeys. After successful trials on man, the com­

grams, guided tours, lectures and exhibits at

pany got clearance from the Food and Drug

medical meetings.

Administration to market the new tranquilizer.

Most important of all are the detail men.

In harmony with the company’s New Bruns­

Major pharmaceutical houses have squads of

wick laboratory policy of naming experimental

detail men who personally call upon physicians

products after nearby communities, this drug was

to introduce and promote new products and an­
swer questions relating to them. It is the job of

called Miltown— adapted from Milltown, drop­

the detail man to develop in the physician enough

ping one “ 1.” With that most unmedical name, the
drug went to market. Initially, it was a slow

interest in the new product so that he will pre­

burner with monthly sales of scarcely $7,500.

scribe it. A detail man may have a territory in­

Sales perked up after an advertising organization

cluding 200 doctors, 40 retail drugstores, and

was hired to stir up publicity, and after several

10 hospitals. Estimates of the total number of

complimentary articles about it appeared in a

detail men employed by the pharmaceutical in­

learned medical journal. But it really caught fire

dustry range from 10,000 to 12,000. Detailing

when the movie colony in Los Angeles began

accounts for the lion’s share of promotional ex­

buzzing about tranquilizers in general and Mil-

penditures of a large house. Total promotional

town in particular. Unlike most drugs, its name

expenditures for the year in which a new product

was easily pronounceable and, better still, lent

is launched by a company may run to as much

itself to punsters and jokesmiths on TV screens

as $2Y2 million.

in the homes of millions of people. Example:

Midst the maelstrom of mood drugs, it is

“ Miltown Berle,” or “ The Government is giving

apparent that a new drug, regardless of its in­

out a Miltown with every income tax blank,” or

herent merits, encounters gigantic competition

“ Use a Miltown instead of an olive to make a

and needs a mighty big push to get recognition

‘Miltini.’ ” Demand for the product exploded

and acceptance. That is one reason why each

like a conflagration, and the company had to

tranquilizer has a trade name as well as a generic

struggle mightily to satisfy the market. Annual

name. If a doctor prescribes by generic name,

sales of Miltown and the basic powder shot up

the druggist may fill the prescription with any
of several manufacturers’ products he may hap­

to a $25 million peak.
Ever-mounting publicity eventually boomer-

pen to have on his shelves. But if the M.D. pre­

anged. Doctors became hesitant to write Miltown
on their prescriptions, which everybody could

scribes by the trade name, that’s it; and the
druggist may not substitute another virtually

understand, and shifted to other tranquilizers

identical drug without the doctor’s permission.

with more medical syllabification. Sales of Miltown began to fall off as its own popularity

When Miltown caught fire

hastened the appearance of a host of competing

Miltown is an example of how a small company

tranquilizers. When the wisecrackers on screen

hit the jackpot. Wallace Laboratories, division of

and radio finally exhausted the bag of jokes

Carter Products (Little Liver Pills), developed a

about Miltown and shifted their attention to

tranquilizer— meprobamate— that calmed down

Sputniks which had just appeared in the skies,

8




b usin ess r e v ie w

TRENDS OF ANNUAL DEATH RATES FROM ALL
CAUSES BY AGE GROUPS, 1900-1952
AN N UAL DEATH RATE PER 1,000 POPULATION

Miltown became just one of many tranquilizers,

people are sick most of the time, and most people

and something had to be done. Quietly, the com­

are sick some of the time, so there is a constant

pany brought out a new tranquilizer named
Meprotabs— a restyled Miltown wearing a differ­

demand for drugs. Moreover, the population is

ent coat.

consume more drugs than those in the prime of

growing in numbers and longevity. Old people
life. Another peculiarity about demand is that the

^ FOR PROFITS

consumer of ethical drugs is utterly helpless about

It is no secret that the pharmaceutical industry

what drug he buys, how much he buys, whose

is profitable. It is one of the most profitable of

drugs he buys, and how much he pays. When

manufacturing industries. Every year from 1950

you’re sick, you take what the doctor prescribes.

through 1957, the manufacturers of drugs and

In the ultimate analysis, it’s the microbes that

medicines made a larger return on net assets than

determine- the total demand curve, the doctors

manufacturing industries generally. How do they

determine what company shall profit by your

do it?

illness, and you pay the bill.

Well, it’s a peculiar industry. Illness doesn’t

The price of a drug is influenced by its cost

ride up and down with the business cycle. Some

of production, the number of companies produc­




9

b usin ess re v ie w

ing it, whether or not there is another drug that

BARNYARD DRUGS

will do the same job, and the patent situation.
The fewer the companies producing a drug, the

Have you noticed that animals in the barn­

higher the price is likely to be. A patent is a

yard are friskier than they used to be? It is

first-class price prop while it lasts, but in this

because they are getting antibiotic supple­

business it is seldom long before a competitor

ments in their feed. As a result, calves, pigs,

brings out something just as good or perhaps

lambs, and beef cattle grow faster; cows

even better.

give more milk; hens lay more eggs; and

Price-wise, some of the strangest bedfellows

broilers produce more meat. O f course all

are to be found in this occult industry. A drug
for which one manufacturer charges the druggist

this adds to the farm surplus problem, but it
is being done more scientifically.

S3 a bottle, with a generic label, may be priced

Animals also need tranquilizers. It shouldn't

at $18 a bottle with a trade label by another

surprise you that animals on the way to the

house, though the two products are identical.

slaughterhouse get nervous and apprehen­

Sweet are the uses of neology!

sive, so much so that they lose weight— which

The record of good earnings in this industry is,

partially defeats the purpose of the trip. By

of course, based upon the reports of the large

feeding them tranquilizers before they leave

companies, but they make most of the drugs.

home, they face death with equanimity, if

Large companies can make money and small com­

not actual joy. A t least they don't lose weight.

panies can make money, and all of the large

Tranquilizers are also being used to facili­

companies once were small. It is also easy to lose

tate live capture of wild animals in the forests

your shirt in this strange industry, and that is

and denizens of the deep. To get a cardi­

why industry is spending ever-increasing sums

ograph of a whale off the coast of California,

of money on research. For example, research ex­

the beastwas tamed with a harpoon equipped

penditures by the industry rose from $127 mil-

with a tranquilizer warhead. This may mean

AVERAGE LENGTH OF LIFE:
DEATH-REGISTRATION STATES, 1900-1953
YEARS

that in commercial whaling the familiar cry,
"Thar she blows!" may become "The Needle,
A h a b !"

AVERAGE LENGTH OF LIFE TOTAL POPULATION

lion in 1957 to $170 million in 1958, and $190
million has been budgeted for 1959. The leading
companies spend an average of about 7 per cent
of their sales for medical, agricultural, and chem­
ical research. That’s a good deal more than most
other industries spend.

BUGS BITING THE DUST
___ 1
____________ 1
___________ J ____________ 1
____________ 1
____________ 1
_______
1900
1910
1920
1930
1940
1950

10



Research teams of the pharmaceutical industry,

b u sin ess r e v ie w

DECLINE IN TUBERCULOSIS DEATHS

to 68.7 years in 1953. In 1956, the expectation

Death rates per 100 ,0 0 0
estimated m id-year population.

of life at birth increased further to just a shade
short of 70 years; however, this may have been

DEATH RATES

pulled down slightly in 1957 by the influenza
50

epidemic in the last quarter of that year. Note
N
5
—

_

5

in the chart the havoc wrought by the 1918 in­

s

i

5

fluenza pandemic.

:r
O J
5 3

1_
«0
0
(
U
_

_

According to mortality conditions prevailing
Z

*

j<
11
11

at the turn of the century, one-fourth of the new­
,1

2 8

Source: National Office of Vital Statistics.

the Government, universities, and independent
foundations are striking terror into the little
world of hostile microbes. One by one the bad
bugs are biting the dust. Meningitis, pneumonia,
tuberculosis, and syphilis, and other heretofore
fatal scourges of mankind have become casualties
of the scientific attack.
Since the introduction of sulfa drugs in 1937,
deaths from influenza-pneumonia have declined
75 per cent. The principal diseases of child­
hood— scarlet fever, streptococcal sore throat,
diphtheria, whooping cough, and measles— which
caused 10 deaths per 100,000 children in 1945,
dropped in the space of 10 years to one death
per 100,000, a decline of 90 per cent. According
to unpublished data of the National Office of
Vital Statistics, the mortality from all infectious

born would fail to reach their 25th birthday.
Now less than 5 per cent of the newborn face that
dismal destiny.
The sulfa drugs, antibiotics, hormones, and
vaccines have not only increased longevity but
decreased misery. People recover from illness
much faster than formerly. Prior to the advent
of these wonder drugs, pneumonia patients who
survived had to spend 100 to 110 days in the
hospital; but as a result of the sulfa drugs, the
pneumonia patient’s hospital stay was cut down
to about 18 days. Subsequent to the introduction
and use of penicillin and the wide spectrum
drugs, the pneumonia patient’s hospitalization
has been cut down still further to about nine days.
In each successive advance, the amount of time

INCREASE IN DEATHS FROM DISEASES
OF HEART AND CIRCULATION
Death rates per 100 ,0 0 0
estimated mid-year population.
DEATH RATES

diseases dropped in a half-century from 672.2 per
100,000 in 1900 to 44.3 per 100,000 in 1956. The
steepest declines in mortality have been in the
younger age groups, as shown in the chart. After
age 44, the declines have been slow and moderate.
As the age-adjusted death rate goes down, life
expectancy goes up. As shown in the single-line
chart, the average duration of life for the total
population has increased from 47.3 years in 1900




11

b usin ess re v ie w

DEATH RATES FOR THE TEN LEADING CAUSES OF DEATH IN 1900,
AND DEATH RATES FOR THESE SAME CAUSES IN 1956*
Rank
(1900)
1
2
3
4
5
6
7
8
9
10

Rate per 100,000
population

Cause of death
(Sixth revision of international lists, 1948)
Influenza and pneumonia .......................................................................
Tuberculosis, all f o r m s ...........................................................................
Gastro-enteritis .....................................................................................
Diseases of the heart
.................................................................
Cerebral hemorrhage and other vascular lesions affecting central
nervous system ...................................................................................
Chronic nephritis ...................................................................................
All a c c id e n ts ...........................................................................................
Cancer and other malignant neoplasm s...............................................
Certain diseases of early in fa n c y ...........................................................
Diphtheria ...............................................................................................
All c a u s e s .....................................

1900

1956

202.2
194.4
142.7
137.4

28.2
8.4
4.5
360.5**

106.9
81.0
72.3
64.0
62.6
40.3
1,719.1

106.3
f
56.7
147.9
38.6
0.1
935.4

* Some of the progress is accounted for by better diagnosis.
** Part of the cause for the rising incidence of heart diseases is the fact that more people live to attain the age o f ca rdiac trouble,
t Not com parable because of change in classification.

required for Nature to cure the patient has been

cancer, the cure rate is already better than 30 per

reduced.

cent. It has been predicted that an effective cure
for cancer will be obtained by 1965. By 1962,

UNFINISHED BUSINESS

it is expected, we will have developed a heart-

All of us are indebted, and some of us more than

disease drug, as well as drugs for mental disease,

we know, to the great pioneering scientists like

and an effective vaccine for the common cold.

Pasteur, Fleming, Florey, Waksman, Chain, Salk,

As this goes to press, comes the announcement

and many others who have made epochal break­

that four young British scientists have isolated

throughs in the relentless battle on the bugs.

in pure form the basic substance of penicillin

Nevertheless, the job of banishing disease still
has a long way to go. The accompanying table
summarizes some of our major accomplishments,

INCREASE IN CANCER DEATHS

as well as the unfinished business. Diseases like

Death rates per 100,000
estimated m id-year population.

pneumonia and tuberculosis are no longer tak­
ing a frightful toll, and diphtheria is all but
conquered.
Diseases of the heart and cancer, as the table
shows, are now the major killers. Among the
principal causes of morbidity are the common
cold, arthritis, rheumatism, and mental diseases
(tranquilizers do not cure mental diseases). All
these diseases and others are under attack and in
time, no doubt, will be conquered. For operable

12




DEATH RATES

b u sin ess re v ie w

which could lead to countless “ tailor-made” peni­

bug bomb that will annihilate any and all bugs

cillin varieties capable of defeating organisms

that may bite you, when all people not killed by

that escape the existing type or have grown re­

accidental causes or homicide will live to a ripe

sistant to it.

old age and just fall apart like the “ wonderful

Will the time ever come when all diseases will

one hoss shay” ? Some virologists tell us that it

have been brought under control? When the

is bound to come and is closer at hand than we

family doctor will carry in his little black bag a

think. Long live the microbe hunters, and more

variety of pills or perhaps some kind of an atomic

power to their armamentaria!




13

HOW DID BANKS
MAKE OUT IN 1958?

When a banker asks “ How is business,” he is not

easier reserve positions, they sought outlets for

likely to be indulging in idle conversation. Trends

available funds. The fact that their earning assets

in production and consumption, in spending and

increased S1 billion to $7.9 billion shows that
/^

saving, and other economic factors, as well as

outlets were found, but suitable lending oppor­

fiscal activities and actions of the monetary au­

tunities were less frequent than investment op­

thorities are grist for his mill. These are the

portunities. They added $260 million to their

materials he uses in appraising current condi­

holdings of United States Government securities

tions and prospects and their potential effect on

during 1958, a year when the marketable debt of

the operations of his bank. During 1958 he had

the Federal Government increased considerably.

to take into account a recession in activity con­

And they increased holdings of other securities,

tinuing into the spring and a marked recovery

chiefly obligations of States and local govern­

in later months.

ments, by $110 million.

In the fore part of the year, the Federal Re­

Approximately $120 million was added to

serve System took several steps to help turn the

loans, but this was only one-fourth of the expan­

recessionary tide. It reduced discount rates and

sion in total earning assets. Real estate credit

reserve

United

accounted for much of the loan increase, with

States Government securities. Later in 1958,

requirements,

and

purchased

smaller additions to business and securities loans,

when business was on the upgrade, the Reserve

and a slight decline in credit extended to individ­

Banks raised their rates.

uals for personal expenditures— automobiles, ap­

Third District member banks borrowed much
less from the Reserve Bank than in 1957. With

14




pliances, remodeling, doctors’ bills, and the like.
Country

bank

loan

portfolios,

adjusted

for

b usin ess re v ie w

mergers, increased 6 per cent, while those of re­
serve city banks were down 1 per cent.
Sharply increased earning assets contributed
to an expansion of nearly S1 billion in deposits
/^
of Third District member banks, lifting the total
to $9.2 billion. Dollarwise, this was the largest
increase on record. Gains, substantial at both
reserve city and country banks, were mainly in
time balances.
Bankers reported an increase of $14 million
to $376 million in total earnings, but their cur­
rent expenses moved up $18 million. Salary out­
lays and miscellaneous expenditures continued
to rise, but most of the increase in expenses was

MEMBER BANKS
Third Fed. Res. District
( Dollar amounts in
millions)
Loans:
Business ......................
Secu rity......................
Real estate ................
To banks ....................
Consumer ..................
All o th e r....................
Total ..................
Less reserves.......
Loans, n e t ......................
U. S. Gov't securities . . .
Other securities.............

Dec. 3 1
,
1958*

Change in year**
Amount
Per cent

$1,740
143
1,242
3
1,180
153
$4,461
114
$4,347
2,632
957

+ $ 28
+
16
+ 88
1
0
+
1
+$123
+
1
2
+ $ l 11
+ 263
+ 11
3

Deposits: Demand .........
Time ..............
Total deposits . . . .
Capital accounts...........

$6,251
2,924
$9,175
912

E a r n in g s , e x p e n se s , an d
p ro fits

Year
1958*

—

+ 2%
+ 1
3
+ 8
5
— 1
+
1
+
+

3%
1
2

+
+
+

3%
II
1
3

+$164
+ 322
+$486
+ 32

+
+

3%
1
2

+
+

5%
4

$ 62.1
24.4
232.1
57.9
$376.5

+$ 3.0
+ 4.5
+ 3.3
+ 3.6
+$14.4

+ 5%
+ 23
+
1
+ 7

$109.1
55.6
85.9
$250.6
$125.9

+$ 5.6
+ 10.7
+ 2.2
+ $ 18.5
— $ 4.1

+ 5%
+ 24
+ 3
+ 8%
3%

+ $ 19.4

+313%

—
+

— 1
9
+ 22

in interest on time deposits, reflecting higher
rates paid and the rising volume of such deposits.
While net earnings from current operations
were off somewhat from 1957, profits on securi­
ties were much more substantial and transfers to
valuation reserves and charged-off losses de­
clined. These changes more than compensated for
the decline in net current earnings and heavier
income tax payments. As a result, net profits
available for distribution moved up from $57
million to $72 million. Relatively little of this
increase, due so largely to non-recurring trans­
actions, was carried over to cash dividends, which
increased only $2 million to $39 million.
The number of member banks in the Third
Federal Reserve District declined from 533 to
513 during 1958. Sixteen member banks merged

Earnings:
On U. S. Gov't
securities.............
On other securities .
On lo an s................
All o th e r................
Total earnings . . .
Current expenses:
Salaries and wages . .
Interest on deposits .
All o th e r................
Total expenses . . .
Net current earnings . .

Recoveries, profits, and
transfers from reserves $ 25.6
Losses, charge-offs, and
32.9
transfers to reserves .
46.2
Taxes on incom e.........
Net profits ................ $ 72.4
Cash dividends declared
39.2

7.9
8.2

+$ 1
5.0
+ 2.1

+

4%

+ 26%
+ 5

*Preliminary tabulations.
**Adjusted tor mergers, etc.

into or were purchased by other members in the
District, two by members in the Fourth District,

banks absorbed five nonmembers in the course

and two by nonmember banks. District member

of the year.




15

FO R THE R E C O R D . . .

Third Federal
Reserve District

Factory*

United States

Per cent change

Ja n . 1959
from
mo.
ago

LOCAL
CHANGES

Ja n . 1959
from

year
ago

mo.
ago

— i
+ 8
+ 1

+ 2
+ 2
— 4

+ 8
+ 1
2
- 3

EMPLOYMENT AND
IN C O M E
— 3
+ 3

— 1

— 2

— 5
— 1

+ 6
+ 1

— 3
+ 1

+ 6
+ 3

Per cent
change
Ja n . 1959
from

Per cent
change
Ja n . 1959
from

Per cent
change
Ja n . 1959
from

Per cent
change
Ja n . 1959
from

mo.
ago

mo.
ago

mo.
ago

mo.
ago

Reading

- 3
— 1
+ 1
+ 2
— 1
— I3f

+
+
+
+
+
+

+
+
+
+
+
+

9
8
1
7
1
8
1
4
4

6*

1*

0
0

+
+

1

+

.......

Scranton .......

1
1

W holesale .........................
Consumer ...........................
‘ Adjusted for seasonal variation.

f20 Cities

{ Philadelphia

1

year
ago

year
ago

year
ago

0

-

2

0 -

— 10 + 6

1 + 8 + 9 +29
1 + 3 -

0 + 1 — 6 + 7
0
0

0 + 1 — 7 + 3
5

7 + 6 — 1

3 0

— 2 — 3 — 1

year
ago

— 9 — 2

— 2 — 2 — 2 — 1

Trenton .........

7f

— 4
0
+ 1
+ 1
— 1
— 7

9
5
1
5
17

year
ago

Philadelphia . — 1 -

PRICES




Per cent
change
Ja n . 1959
from

Lancaster . . . .

- 1
— 1

BAN KIN G
(A ll member banks)
Deposits ............................
Loans .................................
Investments .......................
U.S. Govt, secu rities....
Other ................................
Check payments ..............

Stocks

Lehigh V a lle y . — i — 7 — 5 — 9
Harrisburg .. .

TRADE*
Department store sales . . .
Department store stocks ..

Sales

year
ago

OUTPUT
— 2
— 6
+ 2

Payrolls

mo.
ago

Per cent change

Factory employment
(Total) ..............................
Factory wage incom e.......

Check
Payments

Em ploy­
ment

SUM M ARY

Manufacturing production.
Construction contracts . . .
Coal mining .....................

Department Storef

0 + 8

0 -

0 -13

+ 8

3 — 14 — 4

0 + 2 —1 — 2
6

0 -

7 +

1 -

1 — 2 +

4
1 + 1 + 2 - II

Wilkes-Barre .

0 -

3

0 -

1 — 6 -

2 — 2 — 1 — 5 + 9

W ilm ington ..

0 — 4 + 4 + 4 + 4 + 1 + 8 + 8 -17
2

York ..............

-

1 -

2 +

— 8

+32

1 + 5 — 6 + 5 — 1 + 6 — 4 + 3

*Not restricted to corporate limits of cities but covers areas of one
or more counties.
{Adjusted for seasonal variation.